Loading insider details...
Beta
Latest Form 4 (Apr 8, 2025): Sale of 3,678 PHAT shares, $16.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 8, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 3,678 | $16.7K |
| Mar 3, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 72,000 | n/a |
| Jan 23, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 6,583 | $43.4K |
| Dec 20, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 1,291 | $10.3K |
| Jul 17, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 4,325 | $50.7K |
| May 31, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 7,500 | n/a |
| Apr 10, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 3,435 | $38.1K |
| Jan 23, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 6,307 | $48.9K |
| Nov 21, 2023 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 2,127 | $15.4K |
| Nov 3, 2023 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 22,500 | n/a |